Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Steele

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
Molecular Cancer Therapeutics|November 22, 2017
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine CancerShruthi Naik, Gina D Galyon, Nathan J Jenks, et al.
Journal of Food Protection|January 14, 2004
Frozen storage of Escherichia coli O157 in buffered peptone water and its detection on bovine carcassesH E Ternent, G T Innocent, L M Filshie, et al.
European Journal of Human Genetics : EJHG|February 5, 2015
A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variantsEva Lenassi, Ajoy Vincent, Zheng Li, et al.
Journal of Medical Genetics|December 3, 2011
Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher StudyPolona Le Quesne Stabej, Zubin Saihan, Nell Rangesh, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
NPJ Precision Oncology|August 15, 2025
Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Epidemiology and Infection|November 9, 2005
Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999G T Innocent, D J Mellor, S A McEwen, et al.
NPJ Precision Oncology|March 30, 2026
Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
Molecular Cancer Therapeutics|November 22, 2017
Comparative Oncology Evaluation of Intravenous Recombinant Oncolytic Vesicular Stomatitis Virus Therapy in Spontaneous Canine CancerShruthi Naik, Gina D Galyon, Nathan J Jenks, et al.
Journal of Food Protection|January 14, 2004
Frozen storage of Escherichia coli O157 in buffered peptone water and its detection on bovine carcassesH E Ternent, G T Innocent, L M Filshie, et al.
European Journal of Human Genetics : EJHG|February 5, 2015
A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variantsEva Lenassi, Ajoy Vincent, Zheng Li, et al.
Journal of Medical Genetics|December 3, 2011
Comprehensive sequence analysis of nine Usher syndrome genes in the UK National Collaborative Usher StudyPolona Le Quesne Stabej, Zubin Saihan, Nell Rangesh, et al.
Molecular Therapy. Methods & Clinical Development|September 12, 2022
Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an <i>H</i> <i>.</i> <i>pylori</i> immunostimulatory bacterial transgeneKimberly B Viker, Michael B Steele, Ianko D Iankov, et al.
Molecular Therapy Oncolytics|August 26, 2020
Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic CancersBolni Marius Nagalo, Camilo Ayala Breton, Yumei Zhou, et al.
NPJ Precision Oncology|August 15, 2025
Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Molecular Therapy Oncolytics|July 13, 2018
Preclinical Development of Oncolytic Immunovirotherapy for Treatment of HPV<sup>POS</sup> CancersLukkana Suksanpaisan, Rong Xu, Mulu Z Tesfay, et al.
Epidemiology and Infection|November 9, 2005
Spatial and temporal epidemiology of sporadic human cases of Escherichia coli O157 in Scotland, 1996-1999G T Innocent, D J Mellor, S A McEwen, et al.
NPJ Precision Oncology|March 30, 2026
Author Correction: Epigenetic determinants of an immune-evasive phenotype in HER2-low triple-negative breast cancerAndrés F Bedoya-López, Sookyung Ahn, Miquel Ensenyat-Mendez, et al.
Pageof 12